176 related articles for article (PubMed ID: 7648727)
1. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
[TBL] [Abstract][Full Text] [Related]
2. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
3. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE
Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194
[TBL] [Abstract][Full Text] [Related]
4. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
5. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
[TBL] [Abstract][Full Text] [Related]
6. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.
Bax JJ; Cornel JH; Visser FC; Fioretti PM; Huitink JM; van Lingen A; Sloof GW; Visser CA
J Nucl Cardiol; 1997; 4(4):302-8. PubMed ID: 9278877
[TBL] [Abstract][Full Text] [Related]
7. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
8. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
9. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
[TBL] [Abstract][Full Text] [Related]
10. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
[TBL] [Abstract][Full Text] [Related]
13. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
[TBL] [Abstract][Full Text] [Related]
17. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution.
Marin-Neto JA; Dilsizian V; Arrighi JA; Freedman NM; Perrone-Filardi P; Bacharach SL; Bonow RO
Circulation; 1993 Oct; 88(4 Pt 1):1736-45. PubMed ID: 8403320
[TBL] [Abstract][Full Text] [Related]
18. Present assessment of myocardial viability by nuclear imaging.
Saha GB; MacIntyre WJ; Brunken RC; Go RT; Raja S; Wong CO; Chen EQ
Semin Nucl Med; 1996 Oct; 26(4):315-35. PubMed ID: 8916320
[TBL] [Abstract][Full Text] [Related]
19. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
[TBL] [Abstract][Full Text] [Related]
20. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.
de Silva R; Yamamoto Y; Rhodes CG; Iida H; Nihoyannopoulos P; Davies GJ; Lammertsma AA; Jones T; Maseri A
Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
